Insulin resistance is linked to metabolic syndrome and abdominal fat. Diabetes type 2 is caused by insulin resistance.
Visceral fat from abdominal obesity causes inflammation. Insulin resistance, metabolic syndrome, and abdominal obesity are linked by inflammation.
Abdominal obesity and metabolic syndrome independently raise cardiovascular disease risk. High blood pressure, irregular lipids, and insulin resistance increase cardiovascular risk.
Abdominal obesity and metabolic syndrome increase the risk of heart disease, stroke, and other cardiovascular disorders.
Abdominal obesity and metabolic syndrome raise blood pressure, increasing hypertension risk.
These disorders can cause chronic inflammation that can lead to chronic illnesses.
A healthy lifestyle, including regular exercise and a balanced diet, is essential for treating abdominal obesity and metabolic syndrome.
Lifestyle and early intervention can improve health outcomes, even while genetics predispose to abdominal obesity and metabolic syndrome.